RG7112 |
RG7112 : Antagonist of MDM2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MDM2 |
|
|
Antagonist
Up to 1 uM
Selectivity
Potency Cellular
In Vitro
MDM2
Mode of Action: Antagonist
Structure-Activity-Relationship data available? No
In Vivo Validations
Nude mouse
Dose: 50 mg/kg
Route of delivery:
Oral
Plasma half life:
8.8 h
Organ of interest (O):
Subcutaneous xenografts (GBM and osteosarcoma), Brain engraftment (GBM)
Target engagement assay:
In subcutaneous GBM xenografts, RG7112 increase expression of MDM2, p53 and p21.
Reference: --
Chemical Information
| Molecular Formula | C38H48Cl2N4O4S |
| SMILEs | CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1 |
| InChI | InChI=1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3/t37-,38+/m0/s1 |
| Molecular weight | 726.28 Da |
| AlogP | 7.7549 |
| HBond acceptors | 8 |
| HBond donors | -- |
| Atoms | 97 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.